广发纳斯达克生物科技人民币(001092)

动态评分: 5.28分

投资组合

报告日期 名称 比例
2019-12-31 Avadel Pharmaceuticals plc ADR 0.04%
2019-12-31 BioCryst Pharmaceuticals Inc 0.04%
2019-12-31 Corbus Pharmaceuticals Holdings Inc 0.04%
2019-12-31 CytomX Therapeutics Inc 0.04%
2019-12-31 DBV Technologies SA ADR 0.04%
2019-12-31 ImmunityBio Inc 0.04%
2019-12-31 Inovio制药 0.04%
2019-12-31 Jounce Therapeutics Inc 0.04%
2019-12-31 Puma Biotechnology Inc 0.04%
2019-12-31 Rigel Pharmaceuticals Inc 0.04%
2019-12-31 Calithera Biosciences Inc 0.03%
2019-12-31 Calyxt Inc 0.03%
2019-12-31 Concert Pharmaceuticals Inc 0.03%
2019-12-31 Elanco Animal Health Inc 0.03%
2019-12-31 杰龙 0.03%
2019-12-31 GlycoMimetics Inc 0.03%
2019-12-31 Minerva Neurosciences Inc 0.03%
2019-12-31 Syndax Pharmaceuticals Inc 0.03%
2019-12-31 Arbutus Biopharma Corp 0.02%
2019-12-31 Cellectis SA ADR 0.02%

投资模拟

公告&资料